Local News Research Suggests New Therapeutic Target for Kidney Diseases BU School of Medicine | May 6, 2020 Researchers have published a new study that suggests a signaling pathway called ROBO2 is a…eabramovichMay 6, 2020 Read More
Local News Boston Children’s Hospital to Lead Nationwide Study on COVID-19 in Children Boston Children's Hospital | May 5, 2020 Why are children largely spared from COVID-19 — and why do a tiny handful become extremely…eabramovichMay 5, 2020 Read More
Local News Harvard’s Wyss Institute Joins Forces with Cytosurge to Improve CRISPR-Based Multiplexed Gene Editing Wyss Institute | May 5, 2020 Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Cytosurge AG, a company…eabramovichMay 5, 2020 Read More
Local News Optogenetics with SOUL McGovern Institute | May 4, 2020 Optogenetics has revolutionized neurobiology, allowing researchers to use light to activate or deactivate neurons that are…eabramovichMay 4, 2020 Read More
Local News CRISPR-Based Diagnostic Chips Perform Thousands of Tests Simultaneously to Detect Viruses MIT News | May 4, 2020 Researchers have developed a new technology that flexibly scales up CRISPR-based molecular diagnostics, using microfluidics…eabramovichMay 4, 2020 Read More
Local News Immune System Changes Occur Early in Development of Multiple Myeloma Broad Institute | May 1, 2020 Long before multiple myeloma becomes a malignant disease, the collection of immune system cells and…eabramovichMay 1, 2020 Read More
Local News “Backpacks” Boost Immune Cells’ Ability to Kill Cancer Wyss Institute | May 1, 2020 Macrophages are immune cells that patrol the body looking for potential threats like viruses, bacteria,…eabramovichMay 1, 2020 Read More
Local News Soup to Nuts: Church Lab Tackles the New Coronavirus from Multiple Directions Wyss Institute | April 30, 2020 The COVID-19 pandemic demands action on many fronts, from prevention to testing to treatment. Not content…eabramovichApril 30, 2020 Read More
Local News New Targeted Agent Produces Considerable Responses in Trial with Patients with Uterine Serous Carcinoma Dana-Farber | April 30, 2020 In its first clinical trial in patients with a hard-to-treat form of uterine cancer, a…eabramovichApril 30, 2020 Read More
Local News Rome Therapeutics Debuts with $50M and Rosana Kapeller at the Helm Fierce Biotech | April 29, 2020 In 2018, Rosana Kapeller left Nimbus Therapeutics, the company she built from the ground up,…eabramovichApril 29, 2020 Read More